Intellia Therapeutics Inc Stock Performance
as on April 30, 2026 at 5:08 am IST
Day's Low
Day's High
$11.85$12.95
0.34%
Downside
8.92%
Upside
52 Week's Low
52 Week's High
$6.83$28.2542.56%
Downside
137.59%
Upside
Intellia Therapeutics Inc share price movements today
- Previous Close
- $13.20
- Open
- $12.14
- Volume
- 21.6M
- Day's Low - High
- $11.85 - $12.95
- 52 Week Low - High
- $6.83 - $28.25
Intellia Therapeutics Inc Historical Returns
- 1 Month Return
- + 6.71 %
- 3 Month Return
- -5.04 %
- 1 Year Return
- + 60.98 %
- 3 Year Return
- -65.03 %
- 5 Year Return
- -83.52 %
Intellia Therapeutics Inc Stock Fundamentals & Key Indicators
Check Intellia Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.5B
EPS (TTM)
-3.5439
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
-0.0969
EBITDA
-431.2M
Revenue (TTM)
67.7M
Profit Margin
0.00%
Return On Equity TTM
-53.48%
Intellia Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Intellia Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.5B | -83.52% | NA | 0.00% | |
| BUY | $40.3B | 116.27% | 129.66 | 8.45% | |
| BUY | $108.4B | 103.03% | 27.77 | 32.94% | |
| NA | $33.1B | NA | 120.71 | 5.37% | |
| BUY | $78.0B | 50.88% | 17.95 | 31.41% |
Stock Returns calculator for Intellia Therapeutics Inc Stock including INR - Dollar returns
The Intellia Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Intellia Therapeutics Inc investment value today
Current value as on today
₹1,61,458
Returns
₹61,458
(+61.46%)
Returns from Intellia Therapeutics Inc Stock
₹45,000 (+45%)
Dollar Impact
₹16,458 (+16.46%)
Analyst Recommendation on Intellia Therapeutics Inc Stock
Based on 34 analysts
79.41%
Buy
20.59%
Hold
0.00%
Sell
Based on 34 analysts, 79.41% of analysts recommend a 'BUY' rating for Intellia Therapeutics Inc. Average target price of $26.1
Intellia Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Intellia Therapeutics Inc.
What analysts predicted
54.44%UPSIDE
Target Price
$26.1
Current Price
$11.89
Analyzed by
34 Analysts
Target
$26.10
Intellia Therapeutics Inc target price $26.1, a slight upside of 54.44% compared to current price of $11.89. According to 34 analysts rating.
Intellia Therapeutics Inc Stock’s Investor Sentiment and Interest
Investment in Intellia Therapeutics Inc Shares on INDmoney has grown by 44.91% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:44.91% versus previous 30 day period
Search interest for Intellia Therapeutics Inc Stock has increased by 3% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:3% versus previous 30 day period
Intellia Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Intellia Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Intellia Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Intellia Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Intellia Therapeutics Inc News & Key Events
Insights on Intellia Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 1 Year
In the last 1 year, NTLA has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -101.32M → -95.78M (in $), with an average increase of 5.8% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 13.78M → 23.01M (in $), with an average increase of 40.1% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Intellia Therapeutics Inc. has experienced a drawdown of -65.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 56.3%
NEGATIVE IMPACTPrice Dip
In the last 7 days, NTLA stock has moved down by -20.3%
About Intellia Therapeutics Inc
| Organisation | Intellia Therapeutics Inc |
| Headquarters | 40 Erie Street, Cambridge, MA, United States, 02139 |
| Industry | Biotechnology |
| CEO | Dr. John M. Leonard M.D. |
| E-voting on shares | Click here to vote |
Key Management of Intellia Therapeutics Inc
Name | Title |
|---|---|
Dr. Rachel E. Haurwitz Ph.D. | Co-Founder |
Dr. Derrick J. Rossi Ph.D. | Founder & Member of Scientific Advisor Board |
Prof. Luciano Marraffini Ph.D. | Founder & Member of Scientific Advisor Board |
Mr. Erik J. Sontheimer Ph.D. | Founder & Member of Scientific Advisor Board |
Dr. Eliana Clark Ph.D. | Executive VP & Chief Technical Officer |
Dr. John M. Leonard M.D. | President, CEO & Director |
Mr. Edward J. Dulac III | Executive VP, CFO & Treasurer |
Mr. James E. Basta Esq., J.D. | Executive VP, General Counsel & Corporate Secretary |
Dr. Jennifer A. Doudna Ph.D. | Founder & Member of Scientific Advisor Board |
Dr. Rodolphe Barrangou M.B.A., Ph.D. | Founder & Member of Scientific Advisor Board |
FAQs
What is Intellia Therapeutics Inc share price today?
Intellia Therapeutics Inc share price today is $11.89 as on . Intellia Therapeutics Inc share today touched a day high of $12.95 and a low of $11.85.
What is the 52 week high and 52 week low for Intellia Therapeutics Inc share?
Intellia Therapeutics Inc share touched a 52 week high of $28.25 on and a 52 week low of $6.83 on . Intellia Therapeutics Inc stock price today i.e. is trending at $11.89,which is 57.91% down from its 52 week high and 74.08% up from its 52 week low.
What is Intellia Therapeutics Inc's market capitalisation today?
Intellia Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Intellia Therapeutics Inc Stock (NTLA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Intellia Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Intellia Therapeutics Inc Shares that will get you 0.1262 shares as per Intellia Therapeutics Inc share price of $11.89 per share as on April 29, 2026 at 11:38 pm IST.
What is the minimum amount required to buy Intellia Therapeutics Inc Stock (NTLA) from India?
Indian investors can start investing in Intellia Therapeutics Inc (NTLA) shares with as little as ₹94.82 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.20 in Intellia Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Intellia Therapeutics Inc share’s latest price of $11.89 as on April 29, 2026 at 11:38 pm IST, you will get 0.8410 shares of Intellia Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Intellia Therapeutics Inc has given to Indian investors in the last 5 years?
Intellia Therapeutics Inc stock has given -83.52% share price returns and 27.12% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?